| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/03/2006 | US7115642 Inhibits replication and/or proliferation of Hepatitis C virus (HCV) |
| 10/03/2006 | US7115640 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115638 Amide derivative of amlodipine |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115636 use as antiviral agents; treatment of cytomegalovirus infection |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115633 Benzosuberonylpiperdine compounds as analgesics |
| 10/03/2006 | US7115632 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 10/03/2006 | US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115629 Carbamates derived from arylalkylamines |
| 10/03/2006 | US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 10/03/2006 | US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants |
| 10/03/2006 | US7115626 Treatment of cardiovascular and related pathologies |
| 10/03/2006 | US7115625 Administering mixtures of pyridoxal-5'-phosphate, pyridoxal, pyridoxamine, and analogues, angiotensin converting enzyme inhibitors, angiotensin receptor antagonists, vasodilators and diuretics, for prophylaxis of congestive heart failure |
| 10/03/2006 | US7115624 using heterobicyclic enzyme inhibitors such as 5-(4-Chloro-1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid; autoimmune diseases, inflammation, osteoporosis, cancers, type I diabetes, type II diabetes, and obesity |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115622 Amido ether substituted imidazoquinolines |
| 10/03/2006 | US7115621 Chemical compounds |
| 10/03/2006 | US7115620 Relaxation of smooth muscle cells and reduce smooth muscle contractility; urinary incontinence; irritable bladder and bowel disease; asthma; hypertension; stroke |
| 10/03/2006 | US7115619 N8, N13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115617 Anticarcinogenic and kinase inhibitor; a heteroaryl(containing atleast one oxygen or sulfur atom)amino substituted pyrimidine compound |
| 10/03/2006 | US7115616 Pyrimidinone compounds |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115614 Method of treating brain ischemia |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115612 Arylsulfonamides as antiviral agents |
| 10/03/2006 | US7115611 Phenyl derivatives, their manufacture and use as pharmaceutical agents |
| 10/03/2006 | US7115610 Substituted heterocyclic compounds |
| 10/03/2006 | US7115609 Compounds containing particular phenyl, indolyl or benzo[b]thiophenyl groups, a glycine residue bearing a substituted alkyl group and a 4-(1-methyl-piperidin-4-yl)piperidin-1-yl or 4-(1-methylpiperidin-4-yl)piperazin-1-yl group; Factor Xa inhibitors, thrombotic disorder |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115606 2-(1-piperazinyl) thieno[2,3-d]pyrimidine derivatives having 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity; nocturia or overactive bladder |
| 10/03/2006 | US7115605 Peptide deformylase inhibitors |
| 10/03/2006 | US7115604 Method for treating erectile dysfunction |
| 10/03/2006 | US7115602 Antiinflammatory agents; respiratory system disorders; autoimmune disease |
| 10/03/2006 | US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115598 antagonist to tumor suppression gene ; controlling cell proliferation |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115596 Thiazole compounds as integrin receptor antagonists derivatives |
| 10/03/2006 | US7115595 High oral absorbability; broad range of gram positive and gram negative bacteria including antibiotic resistant staphylococcus pneumonia and hemophilus influenza |
| 10/03/2006 | US7115594 Administering to a patient with metabolic bone disease an effective amount of 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 compound to treat osteoporosis |
| 10/03/2006 | US7115593 Fungicidal combinations of active substances |
| 10/03/2006 | US7115592 antiviral agents for treating HIV-1, HIV-2 or hepatitis B viral infections |
| 10/03/2006 | US7115591 Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders |
| 10/03/2006 | US7115590 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | US7115588 Applying semi-crystalline acetylglucosamine polysaccharide for treating vasoconstriction, reduction in blood flow |
| 10/03/2006 | US7115587 Aripiprazole complex formulation and method |
| 10/03/2006 | US7115586 Non-inclusion cyclodextrin complexes |
| 10/03/2006 | US7115585 Compositions for treating epithelial and retinal tissue diseases |
| 10/03/2006 | US7115584 HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
| 10/03/2006 | US7115582 Useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 |
| 10/03/2006 | US7115581 Autoimmune disease therapy; injections |
| 10/03/2006 | US7115580 antisense compound targeted to human B7; use with antiinflammatory agents or immunosuppressants; modulation of T cell activation |
| 10/03/2006 | US7115579 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 10/03/2006 | US7115578 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 10/03/2006 | US7115577 Colorectal neoplasia prophylaxis |
| 10/03/2006 | US7115576 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 10/03/2006 | US7115575 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 10/03/2006 | US7115565 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 10/03/2006 | US7115564 prolonged serum half-life to permit treatment regimens of about once every 5-7 days or longer, while retaining antibacterial properties in vivo |
| 10/03/2006 | US7115563 vitamin; a metal salt that provides metal ions in vivo; and insulin or a growth hormone |
| 10/03/2006 | US7115559 Administering factor XIII to patients afflicted with bleeding due to a coumarin anticoagulant-induced vitamin K deficiency |
| 10/03/2006 | US7115557 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments |
| 10/03/2006 | US7115556 Use of anti-prolactin agents to treat proliferative conditions |
| 10/03/2006 | US7115545 5-Phenylcarbonyloxy-1-methyl-1H-pyrazol-4-yl)-(8-methyl-sulfonyl-3a,4-dihydro-3H-indeno[1,2-c]isoxazol-5-yl)methanone |
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115405 Recombinantly produced, enzymatically active, includes two amino acid motifs |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115297 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 10/03/2006 | US7115286 Compositions and methods for an orally administered inhibitor of biting insects |
| 10/03/2006 | US7115285 Composition and method for appetite and craving suppression and mood enhancement |
| 10/03/2006 | US7115284 Compositions for diabetes treatment and prophylaxis |
| 10/03/2006 | US7115282 Encapsulated perfumes, flavors, active materials; free-flowing powders |
| 10/03/2006 | US7115281 Mixture of coarse and fine particles; narcolepsy |
| 10/03/2006 | US7115280 Particle formation methods and their products |
| 10/03/2006 | US7115279 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 10/03/2006 | US7115278 Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases |
| 10/03/2006 | US7115277 Delivering low aqueous soluble active agent while avoiding occurrences of side effects |
| 10/03/2006 | US7115275 System for delivering a composition to the nasal membrane and method of using same |
| 10/03/2006 | US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation. |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | US7115251 mixture containing phenolsulfonic acid with sulfosalicylic acid and citric acid |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | CA2535728C Preparation of risperidone |
| 10/03/2006 | CA2489834C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 10/03/2006 | CA2474211C Antiproliferative quinazolines |
| 10/03/2006 | CA2426492C A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 10/03/2006 | CA2394200C Novel forms of pravastatin sodium |
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 10/03/2006 | CA2293367C Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use |